These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 17152789

  • 1. Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
    Schlitt A, Hamilton K, Maegdefessel L, Dahm M, Theis C, Eichler M, Brockmann O, Steinseifer U, Hauroeder B, Hitzler WE, Rupprecht HJ.
    J Heart Valve Dis; 2006 Nov; 15(6):809-14. PubMed ID: 17152789
    [Abstract] [Full Text] [Related]

  • 2. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
    Maegdefessel L, Linde T, Krapiec F, Hamilton K, Steinseifer U, van Ryn J, Raaz U, Buerke M, Werdan K, Schlitt A.
    Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
    [Abstract] [Full Text] [Related]

  • 3. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC, Turpie AG, Dunn AS, Kaatz S, Douketis J, Jacobson A, Petersen H, REGIMEN Investigators.
    Am J Cardiol; 2008 Oct 01; 102(7):883-9. PubMed ID: 18805116
    [Abstract] [Full Text] [Related]

  • 4. Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
    Schlitt A, Buerke M, Hauroeder B, Peetz D, Hundt F, Bickel C, Schaefer I, Meyer J, Rupprecht HJ.
    Thromb Haemost; 2003 Aug 01; 90(2):245-51. PubMed ID: 12888871
    [Abstract] [Full Text] [Related]

  • 5. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
    Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A.
    Thromb Res; 2009 Jul 01; 124(3):262-7. PubMed ID: 19162303
    [Abstract] [Full Text] [Related]

  • 6. In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus.
    Schlitt A, Rupprecht HJ, Reindl I, Schubert S, Hauroeder B, Carter JM, Peetz D, Kropff SS, Maegdefessel L, Russ M, Schmidt H, Ebelt H, Werdan K, Buerke M.
    Coron Artery Dis; 2008 Jun 01; 19(4):279-84. PubMed ID: 18480673
    [Abstract] [Full Text] [Related]

  • 7. Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.
    Kaeberich A, Reindl I, Raaz U, Maegdefessel L, Vogt A, Linde T, Steinseifer U, Perzborn E, Hauroeder B, Buerke M, Werdan K, Schlitt A.
    J Thromb Thrombolysis; 2011 Nov 01; 32(4):417-25. PubMed ID: 21773837
    [Abstract] [Full Text] [Related]

  • 8. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
    Maegdefessel L, Linde T, Michel T, Hamilton K, Steinseifer U, Friedrich I, Schubert S, Hauroeder B, Raaz U, Buerke M, Werdan K, Schlitt A.
    Thromb Haemost; 2009 Jun 01; 101(6):1163-9. PubMed ID: 19492162
    [Abstract] [Full Text] [Related]

  • 9. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P, Tabet JY, Weber H, Renaud N, Ben Driss A.
    Circulation; 2006 Jan 31; 113(4):564-9. PubMed ID: 16449734
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov 31; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 11. [Recurrent thrombosis of a mitral mechanical heart valve prosthesis during puerperium--a case report].
    Lisowska A, Prokop J, Hirnle T, Juszczyk G, Skibińska E, Musiał WJ, Klonowska-Dziatkiewicz E.
    Kardiol Pol; 2004 Jul 31; 61(7):49-51; discussion 52. PubMed ID: 15338018
    [Abstract] [Full Text] [Related]

  • 12. Thrombogenic evaluation of two mechanical heart valve prostheses using a new in-vitro test system.
    Kim CH, Steinseifer U, Schmitz-Rode T.
    J Heart Valve Dis; 2009 Mar 31; 18(2):207-13. PubMed ID: 19455896
    [Abstract] [Full Text] [Related]

  • 13. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.
    James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL.
    J Matern Fetal Neonatal Med; 2006 Sep 31; 19(9):543-9. PubMed ID: 16966122
    [Abstract] [Full Text] [Related]

  • 14. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A, Alban S, Omer-Adam MA, Weitschies W, Warkentin TE.
    Thromb Res; 2008 Sep 31; 122(2):211-20. PubMed ID: 18262226
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant therapy in pregnant women with mechanical heart valves.
    Leyh RT, Fischer S, Ruhparwar A, Haverich A.
    Arch Gynecol Obstet; 2003 Apr 31; 268(1):1-4. PubMed ID: 12673466
    [Abstract] [Full Text] [Related]

  • 16. [Anticoagulation of pregnant women with mechanical heart valve prostheses].
    Lindhoff-Last E, Schinzel H, Erbe M, Schächinger V, Bauersachs R.
    Z Kardiol; 2001 Apr 31; 90 Suppl 6():125-30. PubMed ID: 11826815
    [Abstract] [Full Text] [Related]

  • 17. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.
    Arch Intern Med; 2007 Dec 10; 167(22):2423-30. PubMed ID: 18071163
    [Abstract] [Full Text] [Related]

  • 18. A complication in anticoagulation using low-molecular weight heparin in a patient with a mechanical valve prosthesis. A case report.
    Berndt N, Khan I, Gallo R.
    J Heart Valve Dis; 2000 Nov 10; 9(6):844-6. PubMed ID: 11128796
    [Abstract] [Full Text] [Related]

  • 19. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, Sermer M, Silversides CK.
    Am J Cardiol; 2009 Nov 01; 104(9):1259-63. PubMed ID: 19840573
    [Abstract] [Full Text] [Related]

  • 20. Mechanical valve thrombosis in a chronic animal model: differences between monoleaflet and bileaflet valves.
    Meuris B, Verbeken E, Flameng W.
    J Heart Valve Dis; 2005 Jan 01; 14(1):96-104. PubMed ID: 15700443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.